TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Team Select Home Care says its CareSight AI platform now covers 100% of its patient census through respiratory, cardiac and infection-detection models. The company reported a 14.9% year-over-year drop in hospitalizations from April through August 2026, based on company data shared with Home Health Care News; independent verification and details about the measurement were not provided in the source report.
Team Select Home Care says its CareSight AI platform now covers 100% of its patient census and that its hospitalization rate fell 14.9% year over year from April through August 2026. The Phoenix-based provider shared the results with Home Health Care News, describing them as company data; the report does not establish that the platform alone caused the decline.
CareSight uses machine-learning models developed from more than a decade of Team Select patient records. The platform monitors up to eight vital signs, along with nurse notes and changes in condition, to identify patterns that may signal a patient’s health is worsening. According to President and CEO Fred Johnson, the system is intended to help clinicians spot subtle changes and respond before a patient needs hospital care.
Team Select introduced the platform in 2025, initially focusing on respiratory patients. It later developed a cardiac model and an infection-detection model after examining conditions the company said were associated with hospitalizations. Johnson told Home Health Care News that respiratory-model development took three years, the cardiac model took six months, and the infection model took 90 days. The three models now collectively cover the company’s patient census.
The company said the reported decline compares hospitalization rates from April-August 2026 with the same five months in 2025. The report supplied the 14.9% year-over-year figure but did not provide the underlying patient counts, detailed methodology or a breakdown by model. Team Select is also building a fourth model focused on diabetes, according to the report.
How the Results Could Shape Payer Deals
The reported decline could give Team Select data to use as it seeks or renegotiates value-based contracts, where payment can be tied to outcomes or total care costs rather than only service volume. Johnson said the company expects CareSight to help it pursue more such agreements, particularly as providers face difficulty securing higher fee-for-service rates.
Team Select is also redeveloping payer scorecards. The company says those materials are intended to show measures such as hospitalization and emergency-department visit ratios for a payer’s members, alongside patient feedback and comparisons with industry averages. If the measures are credible and accepted by payers, they may help the provider make a case for contracts that reward reduced hospital use. The available report, however, does not say that any new contract has been awarded or that the reported reduction has produced documented savings.
The development also speaks to how home-care providers are applying predictive tools to medically complex patients. Earlier warnings may support clinical teams in deciding when to intervene, but the value depends on alert accuracy, clinician response and whether improved outcomes can be demonstrated beyond the company’s own data.
patient vital signs monitoring device
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
From Respiratory Care to Full Coverage
Team Select serves medically complex children and seniors at home and operates in 16 states. Private equity firm Court Square Capital Partners invested in the company in 2023. Team Select launched CareSight in 2025 after investing, according to the source report, about $6 million in the effort to build a predictive system from its historical patient records.
The platform expanded in stages because the initial respiratory model could not be applied across all diagnoses. Team Select next built a cardiac model; with those two models, the company said 65% of its patients were covered. It then added infection detection, which brought coverage to the full census. Johnson also said the company adjusted the alert system after early versions generated too many false positives. A patient-specific model lets the system compare readings with that individual’s historical baseline, rather than relying only on general thresholds.
Before CareSight launched, a seven-state Medicaid claims study commissioned by Team Select found a monthly 30-day hospitalization rate of 3% to 8% for the company, Johnson said, compared with an industry average of 10% to 20% per month. Those figures are attributed to the company and relate to an earlier period; they are not the same measure as the 14.9% year-over-year decline reported for April-August 2026.
“I knew that if we could do this, not only would it be a long-lasting competitive advantage … [it] would significantly decrease those hospitalizations even further.”
— Fred Johnson, Team Select Home Care president and CEO
AI-powered health monitoring system
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What the Five-Month Comparison Leaves Open
The source report does not provide the underlying hospitalization counts, the rate before and after implementation, or a detailed definition of how the 14.9% change was calculated. It also does not say whether the comparison adjusts for changes in patient mix, enrollment, location or other factors. The reported figure is company data shared with Home Health Care News, not a result independently validated in the report.
It is also unclear how much of the change, if any, is attributable specifically to CareSight rather than other care changes or broader differences between the comparison periods. The source does not report model-specific outcomes, false-positive rates after the changes, or whether reduced hospitalizations were accompanied by changes in emergency visits, costs or patient outcomes. Johnson cited an earlier claims study for Team Select’s hospitalization rates, but the report does not provide that study’s full methods or data.
As an affiliate, we earn on qualifying purchases.
Diabetes Model and Payer Scorecards
Team Select is developing a fourth CareSight model focused on diabetes, according to the source report. The report does not give a launch date or describe how the new model will be evaluated before it is used across the patient census.
The company also plans to redevelop payer scorecards showing patient-specific hospitalization and emergency-department measures, along with Net Promoter Scores and industry comparisons. Johnson said Team Select intends to use its outcome data in discussions about value-based contracts. Whether payers adopt those measures, agree to outcome-linked payments or see reductions in total cost of care remains to be determined.
As an affiliate, we earn on qualifying purchases.
Key Questions
What is CareSight AI?
CareSight AI is Team Select Home Care’s predictive-care platform. The company says it analyzes up to eight vital signs, nurse notes and changes in condition to flag possible clinical decline.
What did Team Select report about hospitalizations?
Team Select reported a 14.9% year-over-year decline in its hospitalization rate from April through August 2026, compared with the same months in 2025. The result comes from company data shared with Home Health Care News.
Does the report prove CareSight caused the decline?
No. The source report gives a company-reported comparison but does not establish causation or provide enough methodological detail to determine how much of the change is attributable to CareSight.
Which patients are covered by the platform?
Team Select says its respiratory, cardiac and infection-detection models collectively cover 100% of its patient census. The company is developing another model focused on diabetes.
What happens next for CareSight?
Team Select plans to continue developing the diabetes model and use payer scorecards in discussions about value-based contracts. The source does not give a launch date for the model or confirm that new contracts have been signed.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
